BIOSENIC - Daily - Technical analysis published on 08/10/2022 (GMT)
- 127
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
BONE THERAPEUTICS rating 0.3100 EUR. The price registered an increase of +32.76% on the session and was between 0.2800 EUR and 0.3485 EUR. This implies that the price is at +10.71% from its lowest and at -11.05% from its highest.The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
New LOW record (5 years)
Type : Bearish
Timeframe : Weekly
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of BONE THERAPEUTICS indicates that the overall trend is not clearly defined. The trend could quickly turn bullish due to the strong bullish signals currently being given by short-term moving averages. The Central Indicators scanner detects bullish signals on moving averages that could impact this trend:
Bullish price crossover with Moving Average 20
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 50
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 100
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 20
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 50
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 100
Type : Bullish
Timeframe : Daily
In fact, 13 technical indicators on 18 studied are currently bullish. But beware of excesses. The Central Indicators scanner currently detects this:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
MACD indicator: bullish divergence
Type : Bullish
Timeframe : Daily
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Weekly
RSI indicator is back over 50
Type : Bullish
Timeframe : Daily
Parabolic SAR indicator bullish reversal
Type : Bullish
Timeframe : Daily
Aroon indicator bullish trend
Type : Bullish
Timeframe : Daily
Ichimoku : price is over the cloud
Type : Bullish
Timeframe : Daily
SuperTrend indicator bullish reversal
Type : Bullish
Timeframe : Daily
MACD indicator is back over 0
Type : Bullish
Timeframe : Daily
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
Williams %R indicator is back over -50
Type : Bullish
Timeframe : Daily
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
For a small rebound in the very short term, the Central Candlesticks scanner currently notes the presence of these bullish patterns in Japanese candlesticks:
Long white line
Type : Bullish
Timeframe : Daily
Abandoned baby morning star
Type : Bullish
Timeframe : Daily
S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|
ProTrendLines | 0.2420 | 0.3100 | 0.5470 | 0.6930 | 1.0320 |
Change (%) | -21.94% | - | +76.45% | +123.55% | +232.90% |
Change | -0.0680 | - | +0.2370 | +0.3830 | +0.7220 |
Level | Major | - | Intermediate | Intermediate | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.2123 | 0.2212 | 0.2273 | 0.2362 | 0.2423 | 0.2512 | 0.2573 |
Camarilla | 0.2294 | 0.2308 | 0.2321 | 0.2335 | 0.2349 | 0.2363 | 0.2376 |
Woodie | 0.2110 | 0.2205 | 0.2260 | 0.2355 | 0.2410 | 0.2505 | 0.2560 |
Fibonacci | 0.2212 | 0.2269 | 0.2304 | 0.2362 | 0.2419 | 0.2454 | 0.2512 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.2273 | 0.2367 | 0.2463 | 0.2557 | 0.2653 | 0.2747 | 0.2843 |
Camarilla | 0.2508 | 0.2525 | 0.2543 | 0.2560 | 0.2577 | 0.2595 | 0.2612 |
Woodie | 0.2275 | 0.2368 | 0.2465 | 0.2558 | 0.2655 | 0.2748 | 0.2845 |
Fibonacci | 0.2367 | 0.2439 | 0.2484 | 0.2557 | 0.2629 | 0.2674 | 0.2747 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.2013 | 0.2207 | 0.2313 | 0.2507 | 0.2613 | 0.2807 | 0.2913 |
Camarilla | 0.2338 | 0.2365 | 0.2393 | 0.2420 | 0.2448 | 0.2475 | 0.2503 |
Woodie | 0.1970 | 0.2185 | 0.2270 | 0.2485 | 0.2570 | 0.2785 | 0.2870 |
Fibonacci | 0.2207 | 0.2321 | 0.2392 | 0.2507 | 0.2621 | 0.2692 | 0.2807 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 64.61 | |
MACD (12,26,9): | 0.0001 | |
Directional Movement: | 27.9256 | |
AROON (14): | 7.1429 | |
DEMA (21): | 0.2569 | |
Parabolic SAR (0,02-0,02-0,2): | 0.2300 | |
Elder Ray (13): | 0.0545 | |
Super Trend (3,10): | 0.2414 | |
Zig ZAG (10): | 0.3100 | |
VORTEX (21): | 0.9425 | |
Stochastique (14,3,5): | 37.43 | |
TEMA (21): | 0.2646 | |
Williams %R (14): | -32.49 | |
Chande Momentum Oscillator (20): | 0.0595 | |
Repulse (5,40,3): | -4.8129 | |
ROCnROLL: | 1 | |
TRIX (15,9): | -0.2172 | |
Courbe Coppock: | 6.40 |
MA7: | 0.2609 | |
MA20: | 0.2551 | |
MA50: | 0.2665 | |
MA100: | 0.3079 | |
MAexp7: | 0.2643 | |
MAexp20: | 0.2591 | |
MAexp50: | 0.2735 | |
MAexp100: | 0.3472 | |
Price / MA7: | +18.82% | |
Price / MA20: | +21.52% | |
Price / MA50: | +16.32% | |
Price / MA100: | +0.68% | |
Price / MAexp7: | +17.29% | |
Price / MAexp20: | +19.64% | |
Price / MAexp50: | +13.35% | |
Price / MAexp100: | -10.71% |
News
The latest news and videos published on BONE THERAPEUTICS at the time of the analysis were as follows:
- Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
- Bone Therapeutics SA: Information on the total number of voting rights and shares
- Bone Therapeutics optimizes statistical analysis and introduces interim analysis in the ongoing ALLOB Phase IIb study for high-risk tibial fractures
- Bone Therapeutics SA: Information on the total number of voting rights and shares
- Bone Therapeutics Provides First Quarter 2022 Business Update
Add a comment
Comments
0 comments on the analysis BIOSENIC - Daily